BrainCool AB (publ) (BRAIN.ST)
Stockholm · SEK · Healthcare · Medical Devices
SEK 1.07 (+0.00%) as of
Key statistics
- Market cap
- 423.31M
- Forward P/E
- -26.80
- EPS (TTM)
- -0.1100
- Dividend yield
- 0.00%
- 52-week range
- 0.4105 – 1.1500
- Beta
- 1.34
- Revenue (TTM)
- 46.49M
- Profit margin
- -74.07%
- Analyst target
- SEK 1.00
- Volume
- 165.69k
About BrainCool AB (publ)
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter; Cooral system provides medical professionals a way to reduce the risk of oral mucositis; and IQool system, a temperature management system that monitors and controls a patient's temperature. In addition, the company provides products for medical cooling treatments for diseases, such as stroke, cardiac arrest, migraine, and oral mucositis. BrainCool AB (publ) was incorporated in 2010 and is based in Lund, Sweden.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Lund, Sweden
- Employees
- 15
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.